Suven shares up 3% on getting patents for neurological drug

Shares of Suven Life Sciences today gained over 3 per cent after the company said it has been granted a patent each by Israel, Japan and South Africa for a drug used to treat neuro-degenerative diseases.
The stock climbed 3.09 per cent to settle at Rs 233.35 on the BSE. In intra-day, it rose by 5.58 per cent to Rs 239.
At NSE, shares of the drug firm went up by 3.15 per cent to Rs 233.50.
Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's.
In a BSE filing, the company said it has been granted "one product patent from Israel, one product patent from Japan and one product patent from South Africa corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases".

With these, Suven has a total of six granted patents from Israel, 17 from Japan and 20 from South Africa.